NFL Biosciences Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
5
- Stock Symbol
-
ALNFL
- Share Price
-
$0.39
- (As of Friday Closing)
NFL Biosciences General Information
Description
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
Contact Information
Website
www.nflbiosciences.comCorporate Office
- 199 rue Helene Boucher
- Castelnau-le-lez
- 34170 Montpellier
- France
Corporate Office
- 199 rue Helene Boucher
- Castelnau-le-lez
- 34170 Montpellier
- France
NFL Biosciences Stock Performance
As of 13-Nov-2026, NFL Biosciences’s stock price is $0.39. Its current market cap is $4.94M with 12.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.39 | $0.42 | $0.38 - $2.19 | $4.94M | 12.7M | 50.7K | -$0.28 |
NFL Biosciences Financials Summary
As of 30-Jun-2026, NFL Biosciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 10,740 | 13,896 | 15,865 | 8,263 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (4,257) | (4,273) | (2,939) | (4,484) |
| Net Income | (3,547) | (3,743) | (2,252) | (4,053) |
| Total Assets | 5,530 | 4,303 | 3,756 | 4,389 |
| Total Debt | 3,732 | 684 | 43 | 69 |
NFL Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NFL Biosciences Patents
NFL Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4608428-A2 | Methods of treatment involving tobacco leaf extracts to help smoking cessation | Pending | 24-Oct-2022 | ||
| US-20260166111-A1 | Methods of treatment involving tobacco leaf extracts to help smoking cessation | Pending | 24-Oct-2022 | ||
| WO-2024089465-A2 | Methods of treatment involving tobacco leaf extracts to help smoking cessation | Inactive | 24-Oct-2022 | ||
| WO-2024089465-A3 | Methods of treatment involving tobacco leaf extracts to help smoking cessation | Inactive | 24-Oct-2022 | ||
| FR-3049866-A1 | Extract of tobacco leaves and use for treatment of tobacco addiction | Active | 07-Apr-2016 | A61K36/81 |
NFL Biosciences Signals
NFL Biosciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
NFL Biosciences FAQs
-
When was NFL Biosciences founded?
NFL Biosciences was founded in 2006.
-
Where is NFL Biosciences headquartered?
NFL Biosciences is headquartered in Montpellier, France.
-
What is the size of NFL Biosciences?
NFL Biosciences has 5 total employees.
-
What industry is NFL Biosciences in?
NFL Biosciences’s primary industry is Drug Discovery.
-
Is NFL Biosciences a private or public company?
NFL Biosciences is a Public company.
-
What is NFL Biosciences’s stock symbol?
The ticker symbol for NFL Biosciences is ALNFL.
-
What is the current stock price of NFL Biosciences?
As of 13-Nov-2026 the stock price of NFL Biosciences is $0.39.
-
What is the current market cap of NFL Biosciences?
The current market capitalization of NFL Biosciences is $4.94M.
-
What is NFL Biosciences’s annual earnings per share (EPS)?
NFL Biosciences’s EPS for 12 months was -$0.28.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process